Recently published White Paper discusses how innovative clinical laboratories and pathology groups are finding ways to achieve more with less, while finding new ways to grow— despite ongoing changes in the healthcare industry

With less revenue flowing from reimbursements and more consumers footing the bill for diagnostic testing, counterbalancing lost revenue while better serving providers and patients is not an option for clinical labs and pathology groups—it is a must. The year 2016 was one of continuing change for the healthcare industry. The result has been more pressure than ever in 2017 to meet the demands of informed consumers, while balancing new regulations. For clinical laboratories and anatomic pathology...
;